InvestSMART

Volpara Health Technologies Limited (ASX: VHT) - Share Price

DELISTED - Current share price for VHT : $1.145

VHT General Information +

ASX Code VHT
Website N/A
Industry/Sector Health Care Technology
Market Cap ($M) n/a
VHT Share Price $1.145
Day High $1.150
Day Low $1.143
Last Close $1.145
VHT Share Price Movement - ( No change )
Prices as at 16:40, 23 May 2024
+Security prices are delayed by at least 20 minutes and are indicative only.

Volpara Health Technologies Limited (VHT) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Volpara Health Technologies Limited (VHT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Volpara Health Technologies Limited (VHT) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Volpara Health Technologies Limited (VHT)
ORDINARY FULLY PAID
Health Care - Removal from Official List 22 May 2024 9:42AM $1.145 $1.145 fallen by 0%
Volpara Health Technologies Limited (VHT)
ORDINARY FULLY PAID
Health Care - FY24 Annual Unaudited Results 21 May 2024 2:44PM $1.145 $1.145 fallen by 0%
Volpara Health Technologies Limited (VHT)
ORDINARY FULLY PAID
Health Care - Volpara Scheme Implemented 21 May 2024 2:33PM $1.145 $1.145 fallen by 0%
Volpara Health Technologies Limited (VHT)
ORDINARY FULLY PAID
Health Care - Notification of cessation of securities - VHT 13 May 2024 1:38PM $1.145 $1.145 fallen by 0%
Volpara Health Technologies Limited (VHT)
ORDINARY FULLY PAID
Health Care - Receipt of Sealed Final Orders 6 May 2024 3:06PM $1.145 $1.145 fallen by 0%
Volpara Health Technologies Limited (VHT)
ORDINARY FULLY PAID
Health Care - Suspension from Official Quotation 3 May 2024 7:01PM $1.145 $1.145 fallen by 0%

VHT Directors

Name Position Start Date
Ms Teri Jo Thomas Chief Executive Officer, Managing Director 1 Oct 2022

Volpara Health Technologies Limited (VHT) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
17 Aug 2023 BOUW, Mark Issued Options 450,000 $1.300 $585,000.000
2 Jun 2023 THOMAS, Teri Sell Direct Shares 3,577 $0.712 $2,546.109
1 Jun 2023 THOMAS, Teri Buy Direct Shares 75,280 $0.760 $57,213.000

See all changes in directors' interest & trades for Volpara Health Technologies Limited (VHT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

VHT Management

Name Position
Craig Hadfield Chief Financial Officer,Joint Company Secretary
Fred Struve General Counsel,Joint Company Secretary

VHT Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (VHT). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
37,927,963 (14.93%) Harbour Asset Management Limited
18,467,848 (7.27%) Patagorang Pty Ltd
16,213,561 (6.38%) Ralph Philip Highnam

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.